About Lallemand
Located at Rue des Briquetiers in Blagnac, Occitanie, the cosmetic lab at Lallemand leverages biotechnology expertise developed since the 19th century. With 300 scientists driving innovation, this facility contributes to:
- Microorganism development and production
- Specialty cultures and bio-ingredients
- Health solutions and pharma products
- Fermentation processes and microbial solutions
From its French base, Lallemand serves global markets in sectors ranging from cosmetics and pharmaceuticals to oenology, while advancing research in probiotics and biofuels.
Frequently asked questions
Lallemand develops and produces microorganisms and derivatives across multiple sectors:
- Healthcare
- PMBL™ immunostimulant drug
- Healsea™ nasal spray with Symbiofilm™
- Probiotic formulations
- Industrial Applications
- Fermentation ingredients
- Biofuel solutions
- Baking cultures
- Food & Beverage
- Wine fermentation cultures
- Brewing solutions
- Specialty food cultures
The company maintains production facilities that follow international manufacturing standards.
Lallemand’s technological framework includes:
| Technology Area | Applications |
|---|---|
| Microbial Development |
|
| Product Categories |
|
| Research Focus |
|
Lallemand operates globally with the following structure:
- Research Centers
- 300 scientists in R&D teams
- Microbiology laboratories
- Product development facilities
- Manufacturing
- Production plants worldwide
- Regional distribution centers
- Quality control facilities
The company began operations in Canada in the 19th century and has expanded internationally.
More details about Lallemand
About Lallemand: A pioneer in microbial solutions
Founded in Canada at the end of the 19th century, Lallemand has grown into a global leader in the development and production of *microorganisms* and their derivatives. The company operates a cosmetic lab among its numerous research facilities, contributing to innovation across multiple sectors.
Scientific expertise and research capabilities
With a team of 300 scientists working in research and development, Lallemand maintains its position at the forefront of biotechnology. Their work spans from developing fermentation processes to creating new microbial solutions for various industries.
Core business divisions
- Specialty cultures and bio-ingredients
- Pharmaceutical products
- Health solutions and probiotics
- Oenology and brewing solutions
- Plant care and biofuels
Innovation hub in Southern France
Located at 19 Rue des Briquetiers in Blagnac, Occitanie, Lallemand’s French facility plays a key role in the company’s European operations. This strategic location in France’s biotechnology corridor enables close collaboration with regional research institutions and industry partners.
Specialized product development
Pharmaceutical innovations
The company develops specialized products including PMBL™, an immunostimulant drug, and Healsea™, a nasal spray incorporating their proprietary Symbiofilm™ technology for respiratory health support.
Oenology solutions
Since 1970, Lallemand has been advancing winemaking through specialized yeast strains and bacterial cultures. Their expertise in fermentation has made them a reference in the wine industry, particularly in France’s renowned wine regions.
Commitment to sustainable biotechnology
Lallemand’s approach combines traditional fermentation knowledge with modern biotechnology, developing solutions that support sustainable practices across industries, from food production to renewable energy.
Company gallery
